Page 40 - Multiple Sites News Today

As the Focus on Psychedelic Stocks Increases, So Do the Valuations The only companies that have Phase 2 clinical trials now are Compass Pathways, Mind Medicine, Cybin, and Mydecine Innovations. With so many new IPOs and companies launching in the psychedelic industry its important to fully evaluate the major factors of success or failure in the industry. There are various steps that companies take to have a drug approved and to successfully complete them it takes years and tens of milli...